Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that familiar routine of meetings, deadlines, and whatnot has predictably returned. And while this is something of a holiday week for some on this side of the pond, we are forging ahead in search of interesting items. For those of you who can relate, please join us as we quaff a cup or three of stimulation. Southern pecan is brewing today. Meanwhile, here are some tidbits. Hope you have a smashing day and please do keep us in mind when something interesting arises …

Pfizer (PFE) raised the prices of 100 products — the second time this year the drug maker boosted prices for many medicines, according to data seen by The Financial Times. For instance, the average wholesale price of a 100-milligram Viagra pill has gone from $73.85 at the start of this year to $88.45 as of July 1, an increase of 19.8 percent. The latest hikes come just weeks after President Trump claimed the pharmaceutical industry was about to implement “massive” voluntary reductions.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy